✦ LIBER ✦

Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase

✍ Scribed by Ann M McNulty; James E Audia; Kerry G Bemis; Robin L Goode; Vincent P Rocco; Blake Lee Neubauer

Book ID: 117669263
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 279 KB
Volume: 72
Category: Article
ISSN: 0960-0760
DOI: 10.1016/s0960-0760(99)00147-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A non-steroidal diene acid inhibitor of

A non-steroidal diene acid inhibitor of human type 2 stereoid 5α-reductase

✍ Andrew D. Abell; Martin Brandt; Mark A. Levy; Dennis A. Holt 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 261 KB

A series of 4a-methyl-3,4,4a,9-tetrahycIrophenanthrene-2-carhoxyllc acids aud 2-phosphiuic acids has heen prepared and evaluated in vitro as inhibitors of human recombinant steroid Sa-reductase. 7-Chloro-4amethyl-3,4,4a,9-tetrahydrophenauthrene-2-csrhoxylic acid, 5, is a marginally sclectlve inhibit

A comparison of steroidal and non-steroi

A comparison of steroidal and non-steroidal inhibitors of human steroid 5α-reductase: New tricyclic aryl acid inhibitors of the type-1 isozyme

✍ Andrew D. Abell; Martin Brandt; Mark A. Levy; Dennis A. Holt 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 231 KB

ChemInform Abstract: Comparison of Stero

ChemInform Abstract: Comparison of Steroidal and Non-Steroidal Inhibitors of Human Steroid 5α-Reductase: New Tricyclic Aryl Acid Inhibitors of the Type-1 Isozyme.

✍ A. D. ABELL; M. BRANDT; M. A. LEVY; D. A. HOLT 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 35 KB

Phase I and clinical pharmacology of a t

Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action

✍ Mario A. Eisenberger; Menachem Laufer; Nicholas J. Vogelzang; Oliver Sartor; Don 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Responses of LNCaP prostatic adenocarcin

Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α-reductase inhibitor

✍ Sutkowski, Debra M.; Audia, James E.; Goode, Robin L.; Hsiao, Kenneth C.; Leibov 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

We evaluated the metabolic inhibitory, antiproliferative, and antisecretory effects of LY300502, a benzoquinolinone human-specific type I-selective steroid 5a-reductase inhibitor in LNCaP human prostatic adenocarcinoma cell cultures. Reductive metabolism of [3H-T] in the LNCaP cells was inhibited in

ChemInform Abstract: The Preparation and

ChemInform Abstract: The Preparation and Biological Activity of Lactam-Based, Non-Steroidal, Inhibitors of Human Type-1 Steroid 5α-Reductase.

✍ A. D. ABELL; A. J. PHILLIPS; S. BUDHIA; A. M. MCNULTY; B. L. NEUBAUER 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 41 KB 👁 2 views